Skip to main content
Log in

Impact of transcatheter aortic valve replacement on left ventricular hypertrophy, diastolic dysfunction and quality of life in patients with preserved left ventricular function

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

Severe aortic stenosis (AS) is associated with left ventricular (LV) hypertrophy and diastolic dysfunction (LVDD). Due to positive impact on transvalvular hemodynamics, transcatheter aortic valve replacement (TAVR) is expected to improve LV remodeling, LVDD and heart failure (HF)-related quality-of-life (QoL). We identified patients with severe AS and LV ejection fraction (LVEF) ≥ 50% who underwent TAVR. We reviewed pre-procedure, 1-month and 1-year post-TAVR transthoracic echocardiograms to assess LV volumetric changes and diastolic function. QoL was assessed by the Kansas City Cardiomyopathy Questionnaire (KCCQ). In 171 patients studied, we found significant improvement in LV mass index (LVMI), LV end-systolic diameter and LV end-diastolic diameter from baseline to 1-month to 1-year post-TAVR. Predictors of LVMI regression included greater change from baseline in mean aortic valve (AV) gradient, peak AV velocity, and improvements in septal and lateral e’ velocities and E/e’ post-TAVR. The percentage of patients with ≥ grade 2 LVDD decreased from 65% to 53% at 1-month and 49% at 1-year. A significant improvement in symptomatology, as reported by KCCQ score was also noted. There is conceivable reverse LV remodeling post-TAVR, impacted by improvements in mean AV gradient, peak AV velocity, E/e’, medial and lateral e’ velocities, which occurs immediately post-TAVR and persists up to 1-year post-operatively. This is associated with concomitant improvement in LVDD and HF-related QoL as demonstrated by KCCQ scores.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

De-identified data is available for review upon written request.

References

  1. Lorell BH, Carabello BA (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102(4):470–479

    Article  CAS  Google Scholar 

  2. Azevedo CF, Nigri M, Higuchi ML et al (2010) Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol 56(4):278–287

    Article  Google Scholar 

  3. Villari B, Hess OM, Kaufmann P, Krogmann ON, Grimm J, Krayenbuehl HP (1992) Effect of aortic valve stenosis (pressure overload) and regurgitation (volume overload) on left ventricular systolic and diastolic function. Am J Cardiol 69(9):927–934

    Article  CAS  Google Scholar 

  4. Weber KT, Sun Y, Tyagi SC, Cleutjens JP (1994) Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26(3):279–292

    Article  CAS  Google Scholar 

  5. Villari B, Vassalli G, Monrad ES, Chiariello M, Turina M, Hess OM (1995) Normalization of diastolic dysfunction in aortic stenosis late after valve replacement. Circulation 91(9):2353–2358

    Article  CAS  Google Scholar 

  6. Bech-Hanssen O, Caidahl K, Wall B, Myken P, Larsson S, Wallentin I (1999) Influence of aortic valve replacement, prosthesis type, and size on functional outcome and ventricular mass in patients with aortic stenosis. J Thorac Cardiovasc Surg 118(1):57–65

    Article  CAS  Google Scholar 

  7. Treibel TA, Kozor R, Schofield R et al (2018) Reverse myocardial remodeling following valve replacement in patients with aortic stenosis. J Am Coll Cardiol 71(8):860–871

    Article  Google Scholar 

  8. Smith CR, Leon MB, Mack MJ et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198

    Article  CAS  Google Scholar 

  9. Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374(17):1609–1620

    Article  CAS  Google Scholar 

  10. Mack MJ, Leon MB, Thourani VH et al (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380(18):1695–1705

    Article  Google Scholar 

  11. Pellikka PA, Padang R (2018) Diastolic dysfunction pre-transcatheter aortic valve replacement: is it too late? JACC Cardiovasc Interv 11(6):602–604

    Article  Google Scholar 

  12. Park SJ, Enriquez-Sarano M, Chang SA et al (2013) Hemodynamic patterns for symptomatic presentations of severe aortic stenosis. JACC Cardiovasc Imaging 6(2):137–146

    Article  Google Scholar 

  13. Dahl JS, Christensen NL, Videbaek L et al (2014) Left ventricular diastolic function is associated with symptom status in severe aortic valve stenosis. Circ Cardiovasc Imaging 7(1):142–148

    Article  Google Scholar 

  14. Muratori M, Fusini L, Tamborini G et al (2016) Sustained favourable haemodynamics 1 year after TAVI: improvement in NYHA functional class related to improvement of left ventricular diastolic function. Eur Heart J Cardiovasc Imaging 17(11):1269–1278

    Article  Google Scholar 

  15. Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr 29(4):277–314

    Article  Google Scholar 

  16. Baumgartner H, Hung J, Bermejo J et al (2017) Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the european association of cardiovascular imaging and the american society of echocardiography. J Am Soc Echocardiogr 30(4):372–392

    Article  Google Scholar 

  17. Asami M, Lanz J, Stortecky S et al (2018) The impact of left ventricular diastolic dysfunction on clinical outcomes after transcatheter aortic valve replacement. JACC Cardiovasc Interv 11(6):593–601

    Article  Google Scholar 

  18. Blair JEA, Atri P, Friedman JL et al (2017) Diastolic function and transcatheter aortic valve replacement. J Am Soc Echocardiogr 30(6):541–551

    Article  Google Scholar 

  19. Chin CWL, Everett RJ, Kwiecinski J et al (2017) Myocardial fibrosis and cardiac decompensation in aortic stenosis. JACC Cardiovasc Imaging 10(11):1320–1333

    Article  Google Scholar 

  20. Conte L, Fabiani I, Pugliese NR et al (2017) Left ventricular stiffness predicts outcome in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. Echocardiography 34(1):6–13

    Article  Google Scholar 

  21. Dweck MR, Boon NA, Newby DE (2012) Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol 60(19):1854–1863

    Article  Google Scholar 

  22. Hein S, Arnon E, Kostin S et al (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107(7):984–991

    Article  Google Scholar 

  23. Fielitz J, Leuschner M, Zurbrugg HR et al (2004) Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis. J Mol Med (Berl) 82(12):809–820

    Article  CAS  Google Scholar 

  24. Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J (2004) Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol 44(8):1609–1618

    Article  CAS  Google Scholar 

  25. Ali A, Patel A, Ali Z et al (2011) Enhanced left ventricular mass regression after aortic valve replacement in patients with aortic stenosis is associated with improved long-term survival. J Thorac Cardiovasc Surg 142(2):285–291

    Article  Google Scholar 

  26. Biederman RW, Magovern JA, Grant SB et al (2011) LV reverse remodeling imparted by aortic valve replacement for severe aortic stenosis; is it durable? A cardiovascular MRI study sponsored by the American Heart Association. J Cardiothorac Surg 6:53

    Article  Google Scholar 

  27. Ewe SH, Ajmone Marsan N, Pepi M et al (2010) Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosis. Am Heart J 160(6):1113–1120

    Article  Google Scholar 

  28. Imanaka K, Kohmoto O, Nishimura S, Yokote Y, Kyo S (2005) Impact of postoperative blood pressure control on regression of left ventricular mass following valve replacement for aortic stenosis. Eur J Cardiothorac Surg 27(6):994–999

    Article  Google Scholar 

  29. Beach JM, Mihaljevic T, Rajeswaran J et al (2014) Ventricular hypertrophy and left atrial dilatation persist and are associated with reduced survival after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg 147(1):362-369 e368

    Article  Google Scholar 

  30. Castano A, Narotsky DL, Hamid N et al (2017) Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 38(38):2879–2887

    Article  Google Scholar 

  31. Vizzardi E, Sciatti E, Bonadei I et al (2014) Effects of transcatheter aortic valve implantation on left ventricular mass and global longitudinal strain: tissue Doppler and strain evaluation. Heart Lung Vessel 6(4):253–261

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Green CP, Porter CB, Bresnahan DR, Spertus JA (2000) Development and evaluation of the Kansas City cardiomyopathy questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 35(5):1245–1255

    Article  CAS  Google Scholar 

  33. Spertus J, Peterson E, Conard MW et al (2005) Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J 150(4):707–715

    Article  Google Scholar 

  34. Pokharel Y, Khariton Y, Tang Y et al (2017) Association of Serial Kansas City cardiomyopathy questionnaire assessments with death and hospitalization in patients with heart failure with preserved and reduced ejection fraction: a secondary analysis of 2 randomized clinical trials. JAMA Cardiol 2(12):1315–1321

    Article  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge Dr. Georgios Lygouris, Dr. Orestis Pappas, Dr. Rahul Sinha, and Dr. Manik Veer, Department of Cardiovascular Disease, Allegheny General Hospital for supporting the paper during various stages of investigation and manuscript creation.

Funding

The authors have no funding to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manreet K. Kanwar.

Ethics declarations

Conflict of interest

The authors declares that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dahiya, G., Kyvernitakis, A., Joshi, A.A. et al. Impact of transcatheter aortic valve replacement on left ventricular hypertrophy, diastolic dysfunction and quality of life in patients with preserved left ventricular function. Int J Cardiovasc Imaging 37, 485–492 (2021). https://doi.org/10.1007/s10554-020-02015-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-020-02015-z

Keywords

Navigation